• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[取决于体内Vi抗原沉积效应的免疫Vi抗体成熟的基因型特征]

[Genotypical characteristics of the immunological Vi-antibody maturation depending on the effect of Vi-antigen deposit in the body].

作者信息

Bunin K V, Firsanov V I, Kravtsov E G, Shchukin P I

出版信息

Zh Mikrobiol Epidemiol Immunobiol. 1977 Sep(9):49-53.

PMID:596023
Abstract

The authors carried out a comparative analysis of the changes in the antibody synthesis and their immunological maturation in the immunization with various doses of the Vi-antigen of linear rats differing by the capacity to deposit this antigen. August rats with a high capacity to deposit the Vi-antigen (in comparison with Wistar rats in which this capacity was less) were characterized by an increased level of highly avid antibodies. The interlinear differences were found in the character of the changes in the antibody synthesis depending on the immunizing dose of the antigen. Genotypical peculiarities of the immunological maturation of the antibodies were demonstrated. The authors suppose that the described phenomenon was genetically determined and referred to the factors determining the individual immunological reactivity. In the choice of the optimal immunizing doses of the antigens the authors recommend complex determination of the antibody level and the degree of their avidity.

摘要

作者对不同线性大鼠在接种不同剂量Vi抗原时抗体合成及其免疫成熟的变化进行了比较分析,这些大鼠沉积该抗原的能力不同。与Wistar大鼠(其沉积Vi抗原的能力较低)相比,具有高沉积Vi抗原能力的奥古斯特大鼠的特点是高亲和力抗体水平升高。根据抗原的免疫剂量,发现不同品系大鼠在抗体合成变化特征方面存在差异。证明了抗体免疫成熟的基因型特性。作者推测所描述的现象是由基因决定的,并且与决定个体免疫反应性的因素有关。在选择抗原的最佳免疫剂量时,作者建议综合测定抗体水平及其亲和力程度。

相似文献

1
[Genotypical characteristics of the immunological Vi-antibody maturation depending on the effect of Vi-antigen deposit in the body].[取决于体内Vi抗原沉积效应的免疫Vi抗体成熟的基因型特征]
Zh Mikrobiol Epidemiol Immunobiol. 1977 Sep(9):49-53.
2
[Peculiarities of immunological response to the administration of Vi-antigen in patients suffering from typhoid fever and in experimental animals].
Zh Mikrobiol Epidemiol Immunobiol. 1976 Jul(7):25-9.
3
[Immunological paralysis. VI. Split character of the immunological areactivity to the administration of high doses of Vi antigen].[免疫麻痹。VI. 高剂量Vi抗原给药后免疫无反应性的分裂特征]
Zh Mikrobiol Epidemiol Immunobiol. 1974 Nov(11):67-72.
4
[Dependence of the intensity of the immune response on the characteristics of the formation of a Salmonella typhi antigen depot on erythrocytes].[免疫反应强度对伤寒沙门氏菌抗原库在红细胞上形成特征的依赖性]
Zh Mikrobiol Epidemiol Immunobiol. 1987 Apr(4):60-3.
5
[Comparative evaluation of the immunological activity of new typhoid vaccines with established prophylactic effectiveness (data from a controlled experiment)].[对具有既定预防效果的新型伤寒疫苗免疫活性的比较评估(来自对照实验的数据)]
Zh Mikrobiol Epidemiol Immunobiol. 1975 Sep;0(9):63-8.
6
Production of monoclonal antibodies to Vi polysaccharide antigen of Salmonella typhi.伤寒杆菌Vi多糖抗原单克隆抗体的制备。
Asian Pac J Allergy Immunol. 1993 Jun;11(1):53-6.
7
[A study of the avidity of Vi antibodies in typhoid fever patients and chronic carriers].[伤寒患者及慢性带菌者Vi抗体亲和力的研究]
Zh Mikrobiol Epidemiol Immunobiol. 1976 Oct(10):65-9.
8
[Study of X antigen of Salmonella typhi responsible for the production of protective antibody towards chick embryo].[伤寒沙门氏菌X抗原对鸡胚产生保护性抗体作用的研究]
Ann Immunol (Paris). 1977 Jan-Mar;128(1-2):221-3.
9
Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.伤寒沙门菌荚膜多糖(Vi抗原)保护作用的重新审视。
J Infect Dis. 1984 Sep;150(3):436-49. doi: 10.1093/infdis/150.3.436.
10
Mechanisms of antigen-induced blockade of immune response and cyclophosphamide-promoted tolerance to Salmonella typhi Vi antigen.抗原诱导的免疫反应阻断机制及环磷酰胺促进的对伤寒Vi抗原的耐受性
Eur J Immunol. 1980 Aug;10(8):641-6. doi: 10.1002/eji.1830100812.